Related Experiment Videos
Effects of aldehyde-modified proteins on mesangial cell-matrix interaction
G Hasegawa1, K Nakano, Y Tsutsumi
1First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan.
Diabetes Research and Clinical Practice
|February 1, 1994
Summary
Glycolaldehyde-modified matrix proteins, like laminin and fibronectin, impair mesangial cell adhesion and function. Aminoguanidine largely reversed these harmful effects, suggesting a therapeutic target for kidney diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Nephrology
Background:
- Matrix macromolecules are crucial for glomerular mesangial cell function.
- Advanced glycation end-products (AGEs) are implicated in diabetic nephropathy.
- The specific impact of aldehyde-modified proteins on mesangial cells requires further investigation.
Purpose of the Study:
- To investigate the effects of glycolaldehyde (GA)-modified laminin and fibronectin on rat glomerular mesangial cell function in vitro.
- To determine the role of advanced glycation end-products (AGEs) formation in these cellular alterations.
- To evaluate the protective potential of aminoguanidine against GA-induced protein modification and functional impairment.
Main Methods:
- Rat glomerular mesangial cells were incubated with laminin and fibronectin modified by glycolaldehyde (GA).
- Cell adhesion, spreading, and thymidine incorporation were assessed.
- Advanced glycation end-product (AGE) content was quantified using fluorescence spectroscopy.
- The effects of aminoguanidine were evaluated in parallel experiments.
Main Results:
- GA-modified laminin and fibronectin significantly inhibited mesangial cell adhesion.
- GA-modified laminin reduced cell spreading, while GA-modified fibronectin did not.
- GA-modified fibronectin exhibited diminished mitogenic activity.
- Increased AGE content and intermolecular cross-links were observed in GA-modified proteins.
- Aminoguanidine largely restored protein structure and mesangial cell functions.
Conclusions:
- Aldehyde modification of matrix proteins alters their structure and impairs mesangial cell functions, including adhesion and proliferation.
- Formation of AGEs and cross-links in matrix proteins contributes to these detrimental effects.
- Aminoguanidine demonstrates a protective effect, suggesting its potential therapeutic relevance in mitigating matrix protein damage in kidney disease.